Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Pacira BioSciences, Inc. (PCRX) Class Action Lawsuit (January 2025)

In Litigation

26-1500 • January 13, 2025

Class Period Start

June 26, 2023

Class Period End

August 8, 2024

PSLRA Deadline

March 14, 2025

Case Allegations

10b5

Statutes of Repose

Jun 26, 2026

Country

United States

Court

Federal Court

Docket History

Mar 10, 2026

On Appeal

Feb 6, 2026

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Sep 19, 2025

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jul 21, 2025

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Pacira BioSciences, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

May 21, 2025

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jan 13, 2025

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Pacira BioSciences, Inc..

TOP